Provided by Tiger Trade Technology Pte. Ltd.

CONSUN PHARMA

13.600
-0.060-0.44%
Volume:825.00K
Turnover:11.26M
Market Cap:11.41B
PE:9.25
High:13.850
Open:13.660
Low:13.550
Close:13.660
52wk High:18.949
52wk Low:12.310
Shares:839.00M
HK Float Shares:839.00M
Volume Ratio:0.76
T/O Rate:0.10%
Dividend:0.77
Dividend Rate:5.63%
EPS(LYR):1.470
ROE:23.60%
ROA:11.74%
PB:2.16
PE(LYR):9.25
PS:2.86

Loading ...

Consun Pharma repurchases 115,000 shares; treasury stock climbs to 459,000

Bulletin Express
·
May 28

CONSUN PHARMA (01681) Executes HK$1.61 Million Share Buyback on May 28

Stock News
·
May 28

BRIEF-Consun Pharmaceutical Group Announces Share Repurchase Program Up To HKD200 Million

Reuters
·
May 27

CONSUN PHARMA Announces Share Buyback Initiative

Stock News
·
May 27

Consun Pharmaceutical Group Ltd - Share Repurchase Program up to HKD200 Mln

THOMSON REUTERS
·
May 27

Consun Pharmaceutical launches share buyback program of up to HKD 200 million

Reuters
·
May 27

Consun Pharmaceutical held AGM, shareholders approved HKD 0.4 final dividend for 2025

Reuters
·
May 26

Consun Pharma buys back 192,000 shares; treasury stock rises to 344,000

Bulletin Express
·
May 22

Consun Pharma repurchases 102,000 shares for HK$1.47 million; treasury stock rises to 152,000 shares

Bulletin Express
·
May 21

CONSUN PHARMA (01681) Executes Share Buyback, Spending HK$1.47 Million

Stock News
·
May 21

Consun Pharmaceutical files HKEX next-day return disclosing HKD 14.44 share buyback

Reuters
·
May 21

CONSUN PHARMA Repurchases Shares for HK$721,000 on May 20

Stock News
·
May 20

Consun Pharmaceutical files HKEX disclosure return, repurchases shares at HKD 14.42 each

Reuters
·
May 20

Concerns Surrounding Consun Pharmaceutical Group's (HKG:1681) Performance

Simply Wall St.
·
May 07

Consun Pharma Maintains 841.55 Million Issued Shares in April; Public Float Remains Compliant

Bulletin Express
·
May 04

CONSUN PHARMA (01681) Undergoing Valuation Rerating as It Builds Leading "Nephrology Flagship" Competitive Edge

Stock News
·
May 03

Consun Pharmaceutical publishes 2025 ESG report

Reuters
·
Apr 28

CONSUN PHARMA’s 2025 ESG Report: Lower Emissions, Strong R&D Pipeline and RMB 14.76 Billion Brand Valuation

Bulletin Express
·
Apr 28

康臣藥業2025年度業績速覽:收入增長15.2%至34.17億元,腎科板塊領跑業務

Bulletin Express
·
Apr 28

Consun Pharma Schedules 26 May 2026 AGM, Proposes HKD0.40 Final Dividend and New Share Mandates

Bulletin Express
·
Apr 28